Scholars Central

Research articlePublished 2014

The Effect of Novel Rhenium Compounds on Lymphosarcoma, PC-3 Prostate and Myeloid Leukemia Cancer Cell Lines and an Investigation on the DNA Binding Properties of One of these Compounds through Electronic Spectroscopy

Authors: Carl Parson, Valerie Smith, Christopher Krauss, Hirendra N Banerjee, Christopher Reilly, Jeanette A Krause, James M Wachira, Dipak Giri, Angela Winstead, Santosh K Mandal

Journal of Bioprocessing & Biotechniques

Volume 4 · Issue 1 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Despite the tremendous success of cisplatin and other platinum-based anticancer drugs, severe toxicity and resistance to tumors limit their applications. It is believed that the coordination of the metal to DNA bases causes the ruptures of the cancer as well as normal cells. A search for anticancer drugs with different modes of action resulted in the synthesis of variety of novel compounds. Recently we synthesized a series of novel rhenium pentylcarbonato compounds (PC1-PC6). The rhenium atom in each compound is coordinated to a planar heterocyclic aromatic ligand, thereby forcing each compound to intercalate between the DNA bases. The UV absorption titrations of PC6 with DNA shows hypochromic effect with concomitant bathochromic shift of the charge transfer band at 290 nm. These results suggest that the compound PC6 binds to DNA through intercalation. It is likely that many of the other PC-series of compounds will behave in a similar manner. We have observed that the PC-series of compounds are strong cytotoxic agents against lymphosarcoma (average GI50 ≈ 2.3 ± .6 μM), PC-3 prostate (average GI50 ≈ 2.8 ± 0.6 μM) and myeloid leukemia (average GI50 ≈ 3.0 ± .6 μM) cancer cell lines. The average GI50 values of the PC-series of compounds are much less than the corresponding GI50 values of cisplatin. Also each of the PC-series of compounds exhibits less toxicity than cisplatin in the glomerular mesangial cells.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioprocessing & Biotechniques.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioprocessing & Biotechniques
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Carl Parson”
  • BylineArticles whose byline prints “Valerie Smith”
  • BylineArticles whose byline prints “Christopher Krauss”
  • BylineArticles whose byline prints “Hirendra N Banerjee”
  • BylineArticles whose byline prints “Christopher Reilly”
  • BylineArticles whose byline prints “Jeanette A Krause”
  • BylineArticles whose byline prints “James M Wachira”
  • BylineArticles whose byline prints “Dipak Giri”